Description
Introducing Pradaxa 75 Boehringer Ingelheim: Your Anticoagulant Solution
Pradaxa 75 Boehringer Ingelheim is a reliable anticoagulant medication designed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. This product contains the active substance dabigatran etexilate, a direct thrombin inhibitor that effectively manages blood coagulation, making it an essential component in maintaining cardiovascular health for those at risk. With a half-life of 12 to 17 hours, Pradaxa provides lengthy protection in a manageable dosing schedule.
Key Benefits and Advantages of Anticoagulants
Anticoagulants like Pradaxa provide several significant advantages. Using such medications can be pivotal for individuals requiring blood-thinning solutions to prevent cardiovascular problems. The benefits not only enhance the quality of life but also ensure better health management. Here are some essential benefits of using anticoagulants:
- Reduces the risk of stroke in patients at risk.
- Minimises systemic embolism, promoting better blood flow.
- Offers a straightforward dosing schedule that fits seamlessly into daily life.
- Does not significantly affect blood pressure, making it safe for most patients.
These advantages are crucial in making informed choices about health and medication. The features of Pradaxa coupled with its efficient formulation ensure that patients can maintain a balanced lifestyle without the excessive worry of uncontrolled blood clotting.
Long-term Effects and Practical Benefits of Pradaxa 75 Boehringer Ingelheim
When you choose Pradaxa 75 Boehringer Ingelheim for your anticoagulation needs, you are embracing a long-term strategy for heart health. The meticulous development of this medication assures that patients can enjoy a more stable life without the fear of major thromboembolic events. Regarding storage, Pradaxa can be conveniently kept at room temperature, away from moisture and heat, ensuring that you have ready access to your medication whenever needed.
Moreover, regular monitoring of renal function and coagulation parameters is recommended to optimise the treatment’s effectiveness, enhancing the overall therapeutic experience. Patients can experience improved peace of mind knowing that they have a reliable and safe option for managing their health concerns. By integrating Pradaxa into your medical regimen, you can take proactive steps towards a healthier and more secure life, all while benefiting from its innovative formulation designed with patient safety in mind.
Additional information
| Active substance | Dabigatran |
|---|---|
| Water Retention | No significant water retention |
| Hepatotoxicity | No significant hepatotoxicity |
| Lab Test | Monitoring of renal function and possibly coagulation parameters |
| Also known as | Dabigatran |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Typically does not affect blood pressure |
| Trade name | Pradaxa |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | N-{2-[4-(N'-{[(Hexyloxy)carbonyl]carbamimidoyl}carbamimidoyl)phenylaminomethyl]-1-methyl-1H-benzimidazol-5-ylcarbonyl}-N-pyridin-2-yl-beta-alanine ethyl ester |
| Formula | C34H41N7O5 |
| Substance class | Direct thrombin inhibitor |
| Main action | Anticoagulant |
| Half-life | 12 to 17 hours |
| Dosage (medical) | 150 mg or 110 mg twice daily depending on renal function |
| Dosage (sports) | Not applicable as it is not used for sports enhancement |
| Effects | Reduces the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation |
| Side effects | Bleeding, gastrointestinal upset, heartburn, nausea |
| Use in sports | None, as it does not enhance athletic performance |
| Manufacturer | Boehringer |





Reviews
There are no reviews yet.